The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
The Efficacy of GLP-1 Analogues on Appetite Parameters, Gastric Emptying, Food Preference and Taste Among Adults with Obesity: Systematic Review of Randomized Controlled Trials
Open accessAbstract
Background: Obesity is an epidemiological issue that negatively affects public health and has led to a high global burden on the healthcare system. Several approaches to control and overcome the obesity crisis have been established. However, Nobel discoverers found that glucagon-like peptide-1 analogues (GLP-1 analogues) positively regulate appetite and food intake, eventually leading to weight loss. Objective: The present systematic review aims to summarize the currently available evidence of the impact of GLP-1 analogues on appetite, gastric emptying, taste sensitivity, and food preferences among adults with obesity without other chronic diseases. Methods: A systematic literature search was conducted from October 2021 to December 2021 from three electronic databases (PubMed, Scopus, and ScienceDirect), including only randomized clinical trials (RCTs). Studies were based on the use of GLP-1 analogues, of any dosage and duration among adults with obesity without other medical diseases; studies measured appetite, gastric emptying, food preferences, and taste as a primary or secondary outcome. The risk of publication bias in each study was assessed independently using the updated Cochrane risk-of-bias tool (RoB2). Results: Twelve studies met the inclusion criteria with a total sample size of 445 participants. All the included studies measured at least one or more of the primary outcomes. The promising effect was evidenced by most studies showing appetite suppression, delayed gastric emptying, and changes in taste and food preferences. Conclusion: GLP-1 analogues are effective obesity management therapy that could decrease food intake and eventually reduce weight by suppressing appetite, reducing hunger, decreasing gastric emptying, and altering food preferences and taste. However, high-quality, long-term, large sample size studies are crucial to examine the efficacy and effective dose of GLP-1 analogues intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This group of drugs slows the rate of post‐prandial gastric emptying [2, 3, 4]”
From Association between glucagon-like peptide-1 receptor agonist use and peri-operative pulmonary aspiration: a systematic review and meta-analysis (2025) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Page, M. J., Moher, D., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n160 · Cited by 13,262
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Flint, A., Raben, A., Blundell, J., & Astrup, A. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801083 · Cited by 2,238
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Appetite control: methodological aspects of the evaluation of foods
Blundell, J., De Graaf, C., Hulshof, T., Jebb, S., Livingstone, B., Lluch, A., Mela, D., Salah, S., Schuring, E., Van Der Knaap, H., et al. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00714.x · Cited by 1,007
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Secher, A., Jelsing, J., Baquero, A. F., Hecksher-Sørensen, J., Cowley, M. A., Dalbøge, L. S., Hansen, G., Grove, K. L., Pyke, C., Raun, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75276 · Cited by 961
Blundell, J., Finlayson, G., Axelsen, M., Flint, A., Gibbons, C., Kvist, T., & Hjerpsted, J. B. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12932 · Cited by 693
Research works printed but not linked: 4
- Van Bloemendaal, 2014, Diabetes, 2014, 1
- Kadouh, 2020, Cad Saude Publica, 12, 1
- Kamioka, 2019, Japanese Pharmacol Ther, 47, 1177
- Hill, 1995, Int J Obes Relat Metab Disord J Int Assoc Study Obes, 1995, 361
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
Balasubramanian, R., Schneider, E., Gunnigle, E., Cotter, P. D., & Cryan, J. F. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105562 · Cited by 143
van Zuylen, M. L., Siegelaar, S. E., Plummer, M. P., Deane, A. M., Hermanides, J., & Hulst, A. H. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.01.001 · Cited by 132
Do GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies
Szczesnowicz, A., Szeliga, A., Niwczyk, O., Bala, G., & Meczekalski, B. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12185915 · Cited by 83
Le, R., Nguyen, M. T., Allahwala, M. A., Psaltis, J. P., Marathe, C. S., Marathe, J. A., & Psaltis, P. J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164674 · Cited by 66
“…pro-opiomelanocortin/cocaine-and amphetamine-stimulated transcription (POMC + /CART + ), resulting in satiety [35]. beneficial effect of GLP-1 RA therapy has been attributed to the modulatory action of central appetite control, which in caloric restriction and subsequent weight loss [33].”
BackgroundCastrillon, J., Rele, S., Sumithran, P., Hii, M., Thuraisingam, S., Spelman, T., Phan, T., Choong, P., Dowsey, M., & Shadbolt, C. (2025) · Anaesthesia · doi:10.1111/anae.16601 · Cited by 65
Envisioning how to advance the MASH field
Allen, A. M., Younossi, Z. M., Diehl, A. M., Charlton, M., & Lazarus, J. V. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00938-9 · Cited by 68
Milder, D. A., Milder, T. Y., Liang, S. S., & Kam, P. C. A. (2024) · Anaesthesia · doi:10.1111/anae.16306 · Cited by 62
Qassab, M. A., Mneimneh, M., Jradi, A., Derbas, B., Dabboussi, D., Baini, J. K., Katrib, N., Chaarani, N., Attieh, P., Kanaan, A., et al. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47040285 · Cited by 64
Current and future pharmacotherapies for obesity in children and adolescents
Kelly, A. S. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00858-9 · Cited by 54
Yuen, K. C. J., Hjortebjerg, R., Ganeshalingam, A. A., Clemmons, D. R., & Frystyk, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1456195 · Cited by 59
Lee, H. A., & Kim, H. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119324 · Cited by 58
Soto‐Catalán, M., Opazo-Ríos, L., Quiceno, H., Lázaro, I., Moreno, J. A., Gómez‐Guerrero, C., Egido, J., & Mas, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052961 · Cited by 51
Jafar, A. B., Jacob, J., Kao, W. K., & Ho, T. (2024) · Aesthetic Surgery Journal Open Forum · doi:10.1093/asjof/ojae069 · Cited by 46
Pililis, S., Lampsas, S., Kountouri, A., Pliouta, L., Korakas, E., Livadas, S., Thymis, J., Peppa, Μ., Kalantaridou, S., Oikonomou, E. K., et al. (2024) · Medicina · doi:10.3390/medicina60101656 · Cited by 63
Dubin, R. L., Heymsfield, S. B., Ravussin, E., & Greenway, F. L. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15913 · Cited by 47
“32,33 35 Patients report reductions in rumination and obsessive preoccupations with food, or ‘ food noise ’ .”
Anson, M., Henney, A. E., Broadwell, N., Zhao, S. S., Ibarburu, G. H., Lip, G. Y. H., Wilding, J. P. H., Cuthbertson, D. J., & Alam, U. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102777 · Cited by 44
Nascimento, T. S. D., Pereira, R. O. L., Maia, E., Ohnuma, T., da Costa, M. G., Slawka, E., Galhardo, C., & Krishnamoorthy, V. (2024) · Perioperative Medicine · doi:10.1186/s13741-024-00439-y · Cited by 39
Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events
He, L., Li, Q., Yang, Y., Li, J., Luo, W., Huang, Y., & Zhong, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1416985 · Cited by 40
Sievenpiper, J. L., Ard, J. D., Blüher, M., Chen, W., Dixon, J. B., Fitch, A., Gigliotti, L., Khunti, K., Lecube, A., Lean, M., et al. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100228 · Cited by 56
Gut hormones and appetite regulation
Hong, S.-H., & Choi, K. M. (2024) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000859 · Cited by 35
Jiang, Y., Zhu, H., & Gong, F. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16106 · Cited by 36
Salvio, G., Ciarloni, A., Ambo, N., Bordoni, M., Perrone, M., Rossi, S., & Balercia, G. (2025) · Andrology · doi:10.1111/andr.70022 · Cited by 35
GLP-1 receptor agonists significantly impair taste function
Khan, R., & Doty, R. L. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114793 · Cited by 31
Torbahn, G., Lischka, J., Brown, T. J., Ells, L. J., Kelly, A. S., Wabitsch, M., & Weghuber, D. (2024) · Clinical Endocrinology · doi:10.1111/cen.15133 · Cited by 33
GLP-1 receptor agonism: a transformative approach for managing type-2 diabetes and obesity
Alharbi, A. (2025) · Saudi Pharmaceutical Journal · doi:10.1007/s44446-025-00038-y · Cited by 33
Okuma, H., & Tsuchiya, K. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108699 · Cited by 24
Embracing the Pros and Cons of the New Weight Loss Medications (Semaglutide, Tirzepatide, Etc.)
Moyad, M. A. (2023) · Current Urology Reports · doi:10.1007/s11934-023-01180-7 · Cited by 21
The Expanding Scope of GLP-1 Receptor Agonists: Six Uses Beyond Diabetes
Sheth, K., Kim, S., Porterfield, L. R., Virani, S. S., Wadhwani, S., & Vaughan, E. M. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01319-6 · Cited by 21
Keivanlou, M., Amini‐Salehi, E., Hassanipour, S., Zare, R., Mohammadi‐Vajari, E., Hashemi, M., Salari, A., & Porteghali, P. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998284844240102110559 · Cited by 22
Krug, I., Dang, A. B., Portingale, J., Li, Y., & Won, Y. Q. (2025) · Nutrients · doi:10.3390/nu17233735 · Cited by 23
Characteristics and food consumption for current, previous, and potential consumers of GLP-1 s
Dilley, A., Adhikari, S., Silwal, P., L. Lusk, J., & McFadden, B. R. (2025) · Food Quality and Preference · doi:10.1016/j.foodqual.2025.105507 · Cited by 18
Gastrointestinal hormone-mediated beneficial bioactivities of bitter polyphenols
Osakabe, N., Ohmoto, M., Shimizu, T., Iida, N., Fushimi, T., Fujii, Y., Abe, K., & Calabrese, V. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.104550 · Cited by 18
The Effects of Metformin on Weight Loss, Cardiovascular Health, and Longevity
Pillai, A. A., Melo, L., Frishman, W. H., & Aronow, W. S. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000832 · Cited by 19
New drug therapies for metabolic dysfunction-associated steatohepatitis
Chiang, J. Y. L. (2025) · Liver Research · doi:10.1016/j.livres.2025.01.001 · Cited by 19
Fitch, A., Gigliotti, L., & Bays, H. E. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100205 · Cited by 14
Anti-obesity Drugs for the Treatment of Binge Eating Disorder: Opportunities and Challenges
Riboldi, I., & Carrà, G. (2024) · ALPHA PSYCHIATRY · doi:10.5152/alphapsychiatry.2024.241464 · Cited by 15
Jensterle, M., Kovac, J., Vovk, A., Ferjan, S., Battelino, S., Battelino, T., & Janez, A. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf278 · Cited by 12
Current Status of Therapeutic Peptides for the Management of Diabetes Mellitus
Prajapati, A., Rana, D., Rangra, S., Jindal, A. B., & Benival, D. M. (2024) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-024-10590-1 · Cited by 10
Mustafa, Y. F. (2025) · Obesity Medicine · doi:10.1016/j.obmed.2025.100620 · Cited by 11
Ultrasonographic assessment of gastric and gallbladder dynamics in human health and disease
Ciaula, A. D., Khalil, M., & Portincasa, P. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-03905-7 · Cited by 9
Hoffmann, K., Michalak, M., & Paczkowska, A. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s531697 · Cited by 11
Global research trends of diabetes remission: a bibliometric study
Yang, X. Q., He, Z., Chen, Q., Chen, Y., Chen, G., & Liu, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1272651 · Cited by 10
May, W., Goedecke, J. H., & Conradie-Smit, M. (2025) · South African Medical Journal · doi:10.7196/samj.2025.v115i9b.3600 · Cited by 8
Potential role of glucagon like peptide 1 in taste receptors
Doval-Caballero, J. L. E., Ferreira‐Hermosillo, A., Eugenio-Ponce, G. D., García-Sáenz, M. R., Ibarra‐Salce, R., Tenorio-Rojo, A. P., Luna-Ávila, E. S., Palacios, P. C. G., Pérez-Hernández, F., Rojas-Milán, E., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1683419 · Cited by 8
Chen, A., Zhao, K., Ceban, F., Nabipoor, M., Englesakis, M. F., Chung, F. F., & Perlas, A. (2026) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-026-03114-6 · Cited by 8
Jogani, V. G., Elfadil, O. M., Varayil, J. E., & Mundi, M. S. (2025) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001294 · Cited by 10
Independent and Combined Impacts of Obesity and Aging on Chronic Kidney Disease
Ma, Y., Xu, C., Shen, Y., Cheng, Y., & Zhao, W. (2025) · Obesity Reviews · doi:10.1111/obr.70023 · Cited by 8
Health and Well-Being Coaching Adjuvant to GLP-1 Induced Weight Loss
Sforzo, G. A., Gordon, N. F., Peeke, P. M., & Moore, M. A. (2024) · American Journal of Lifestyle Medicine · doi:10.1177/15598276241302273 · Cited by 7
Katsanos, C. S., Liu, Z., & Atherton, P. J. (2026) · Comprehensive physiology · doi:10.1002/cph4.70126 · Cited by 8
Comprehensive insights into emerging advances in the Neurobiology of anorexia
Mao, L., Wang, L., Huang, Z., Chen, J.-K., Tucker, L. D., & Zhang, Q. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.03.046 · Cited by 7
Sun, M., Wang, X., Lu, Z., Yang, Y., Lv, S., Miao, M., Chen, W., Wu, S., & Zhang, J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16434 · Cited by 7
A Semaglutida aplicada ao tratamento da obesidade: perspectivas clínicas na literatura
Zanatta, M. C. A., da Rocha, F. S., Fumagali, T. A. S., Backes, G. A., Sambini, T. B., Matsukuma, I. S., Martinez, G. A., Benedetti, A. T. S., & Pereira, L. A. (2023) · Research Society and Development · doi:10.33448/rsd-v12i9.43295 · Cited by 13
Godziuk, K., Forhan, M. A., Vieira, F. T., Mota, J. F., Werle, J. R., Batsis, J. A., Donini, L. M., Siervo, M., & Prado, C. M. M. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70025 · Cited by 6
Ponzo, V., Vitale, M., Bo, S., Broglio, F., Goitre, I., & Cioffi, I. (2025) · Nutrients · doi:10.3390/nu17213318 · Cited by 5
Common postbariatric surgery emergencies for the acute care surgeon: What you need to know
Cheng, V. C., Samakar, K., Dobrowolsky, A. B., Nguyen, J. D., Abel, S. A., Pakula, A. M., Bernard, A. C., & Martin, M. J. (2023) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000004125 · Cited by 6
Fatima, N., Anand, A., Palvia, A. R., Kaur, A., Azeez, G. A., Thirunagari, M., & Butt, S. R. (2024) · Cureus · doi:10.7759/cureus.68786 · Cited by 6
Industrialized diets modulate host eating behavior via the microbiome–gut–brain axis
Liow, Y. J., Sarkar, A., & Carmody, R. N. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.06.002 · Cited by 8
Qeadan, F., McCunn, A., Tingey, B., & Kroth, P. J. (2026) · Communications Medicine · doi:10.1038/s43856-026-01685-5 · Cited by 4
Rutigliani, G., & Mattes, R. D. (2026) · Physiology & Behavior · doi:10.1016/j.physbeh.2026.115486 · Cited by 4
Tsironikos, G. I., Tsolaki, V., Zakynthinos, G. Ε., Kyprianidou, D., Rammou, V., Antonogiannis, T., Mprotsis, T., Zakynthinos, Ε., & Bargiota, Α. (2025) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2025.1694808 · Cited by 3
Ethical considerations for semaglutide use in children
Ryan, N., Wilkinson, D., & Savulescu, J. (2026) · Archives of Disease in Childhood · doi:10.1136/archdischild-2025-329747 · Cited by 3
Eldesouki, M. H., Alkasabrah, O., Kloub, M., Abosheaishaa, H. M., Elfert, K., Sharma, A., Andrawes, S., & Duong, N. K. (2026) · United European Gastroenterology Journal · doi:10.1002/ueg2.70238 · Cited by 3
Mogna-Peláez, P., & Guasch‐Ferré, M. (2026) · Journal of Nutrition · doi:10.1016/j.tjnut.2026.101684 · Cited by 4
Glucagon‐Like Peptide‐1 Receptor Agonist‐Based Agents and Body Composition: Filling More Gaps
Dubin, R. L., Sanders, T. N., Schwab, H. M., Heymsfield, S. B., & Greenway, F. L. (2026) · Obesity · doi:10.1002/oby.70212 · Cited by 3
Changes in Food Waste among a Sample of U.S. Consumers after Beginning Anti-Obesity Medication
Mansouri, J., & Roe, B. E. (2024) · Nutrients · doi:10.3390/nu16193274 · Cited by 3
The Role of Diet and Hormones on Taste: Low Carb Compared With Low Fat Study Findings
Jaime-Lara, R. B., Franks, A. T., Nawal, N., Steck, M. C., Chao, A. M., Allen, C., Brooks, B. E., Atkinson, M., Courville, A. B., Guo, J., et al. (2025) · Current Developments in Nutrition · doi:10.1016/j.cdnut.2025.107467 · Cited by 3
Benefits of Supplementing a GLP-1 Type Medication With Physical Activity
Ablah, E. A., Imboden, M. T., Zendell, A. L., Hosking, M., Anderson, R. E., VanHoose, K., Peterson, N. E., Wojcik, J. R., Pronk, N. P., Harber, M., et al. (2025) · American Journal of Health Promotion · doi:10.1177/08901171251357130 · Cited by 3
Pediatric Obesity Treatment: Considerations for Diabetes Educators and Clinicians
Laroche, H. H., Fernández, C., Sweeney, B. R., Gillette, M. L. D., & Hampl, S. E. (2024) · Diabetes Spectrum · doi:10.2337/dsi24-0005 · Cited by 3
Yue, D., Hua, X., Zhu, L., Wang, J., Gu, L., Yuan, Z., Jian, W., Chen, Y., & Meng, G. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1684395 · Cited by 2
Tsironikos, G. I., Tsolaki, V., Zakynthinos, G. Ε., Rammou, V., Kyprianidou, D., Antonogiannis, T., Zakynthinos, Ε., & Bargiota, Α. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70114 · Cited by 2
GLP-1 receptor agonists and smoking cessation: therapeutic promise beyond glycemia
Bhaduri, G., Mukherjee, S., Parikh, R. M., Karak, S., & Pal, J. (2026) · Endocrine · doi:10.1007/s12020-026-04559-x · Cited by 2
Personalized Diabetes Therapy Part 2—Individual Diabetes Treatment (Standard of Care Plus, SOC+)
Jantz, J., & Pfützner, A. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16040229 · Cited by 2
Wang, X., Lu, G., Zhou, Y., & Zhao, G. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02891-7 · Cited by 4
Ghusn, W., Fansa, S., Tama, E., Añazco, D., Espinosa, M. A., Villamarin, J. L., Cifuentes, L., Gala, K. S., Hurtado, M. D., & Acosta, A. J. (2026) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2026.02.006 · Cited by 3
Méndez-Pino, L., Goldblatt, J., Godie, D., Ravi, S., Williams, K., Amcheslavsky, J., Guerra‐Londono, C. E., & Ravikant, N. T. (2026) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-026-03187-3 · Cited by 2
Das, S., Ravi, H., Babu, A., Banerjee, M., Ramasubbu, K., Sivaraman, D., Rajeswari, V. D., Venkatraman, G., & Ramanathan, G. (2024) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.12.017 · Cited by 1
Corbalan, J. J., Petronella, B. A., Huang, C., Beasley, J. R., Merritt, J. R., Mugrage, B., & Nickels, J. T. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152360 · Cited by 1
Ma, Y., Chen, S., Shen, Y., Wang, X., Xie, X., & Zhao, W. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1582534 · Cited by 1
Wen, J., Puglisi, J. L., & Frezza, E. E. (2025) · Cureus · doi:10.7759/cureus.96771 · Cited by 2
GLP1 receptor analogues and perioperative management considerations: A narrative review
Lima, A. V., & Lopo, M. V. (2026) · Revista Española de Anestesiología y Reanimación (English Edition) · doi:10.1016/j.redare.2026.501985 · Cited by 1
The Ethics of Wegovy in Pediatric Mental Health
Ryan, N., & Savulescu, J. (2026) · Bioethics · doi:10.1111/bioe.70087 · Cited by 2
Tănăsescu, M., Rosu, A.-M., Mincă, A., Grigorie, M.-M., Timofte, D., & Ionescu, D. (2026) · Life · doi:10.3390/life16050756 · Cited by 1
Xu, H., Li, M., Liu, Y., Nie, G., Li, M., & Meng, Z. (2026) · Toxicon · doi:10.1016/j.toxicon.2026.109152 · Cited by 1
Chen, J.-H., Chen, J.-C., Mei, Y.-J., Zhu, X.-C., Luo, Q.-M., & Tu, Y.-Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1844057 · Cited by 1
Silva, L. S., de Sá, A. L. R., Morais, É. F. B., Silva, J. P., Barros, N. S. F., Lima, P. G. O., & Padilha, P. A. (2024) · Revista Cereus · doi:10.18605/2175-7275/cereus.v16n3p323-336 · Cited by 1
Qin, W., Song, T., Lai, Z., Li, D., Wang, L., & Huang, R. (2025) · eLife · doi:10.7554/elife.108551 · Cited by 4
The Ethical Landscape of Plastic Surgeons Prescribing Weight Loss Medications
Gupta, R., Lin, J., Lund, H., & Kaswan, S. (2026) · Aesthetic Surgery Journal · doi:10.1093/asj/sjag015 · Cited by 1
Pugliese, G., de Alteriis, G., & Savastano, S. (2023) · L Endocrinologo · doi:10.1007/s40619-023-01355-x
Weber, H. C. (2024) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000861
Dubernat, L., Lefevre, A., Marousez, L., Tran, L. C., Hul, M. V., de Lamballerie, M., Cani, P. D., Gottrand, F., Ley, D., & Lésage, J. (2024) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.12285
Outcomes of retained gastrointestinal debris during upper endoscopy
Jacob, J. S., Than, J. K., Tang, C., Cano, J. J., Sheikh, R. A., Wolfson, S. M., Thrift, A. P., Munnur, U., & Sealock, R. J. (2025) · Endoscopy International Open · doi:10.1055/a-2544-2468
GLP-1RA: New Hope in Obesity Therapy
Zhang, D., & Lu, H. (2025) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2025.132035
Xu, Y., Velu, P., Hu, L., & Guimarães, N. S. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01633-8
Rodrigues, C. D. S., Marques, E. A. C., de Almeida, A. V. N., Trindade, M. C., Ramos, T. C. D. S., Vieira, G. D. S. R., & Ivankovics, I. G. (2025) · Brazilian Journal of Health Review · doi:10.34119/bjhrv8n3-047
Zhang, Y. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2025.au23155
Kargutkar, S. (2025) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2025.06.009
GLP-1 agonists in anaesthetic practice - a review of clinical data and recommendations
Pokrywka, N., Polak, M., Suwała, D., Hetnar, P., Fortuna, M., Kiper, S., Toczek, S., Tomala, M., Jastrowicz-Chęć, K., & Koryszko, K. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.83.61812
Qin, W., Song, T., Lai, Z., Li, D., Wang, L., & Huang, R. (2026) · eLife · doi:10.7554/elife.108551.4 · Cited by 1
EFEITOS TERAPÊUTICOS DOS AGONISTAS DO RECEPTOR DO GLP-1: UM ESTUDO DE REVISÃO
Gonçalves, F. M., Araújo, F. D. S., Barbosa, G. F., Presoto, C. L. Z., & Gardizani, T. P. (2025) · Revista Omnia Saúde · doi:10.69719/ros.v8.862
Metadata
- Authors
- Aldawsari, M., Almadani, F. A., Almuhammadi, N., Algabsani, S., Alamro, Y., & Aldhwayan, M.
- Affiliations
- King Saud University (SA)
- Corresponding author
- Aldawsari, Malikah
- Venue
- Diabetes, Metabolic Syndrome and Obesity
- Publisher
- Informa UK Limited
- Published
- 2023-03
- Volume
- Volume 16
- Pages
- 575-595
- ISSN
- 1178-7007 (ISSN-L)
- PMC
- PMC9987242
- OpenAlex
- W4322773858
- Semantic Scholar
- bfb01b3839e12cdd8d7b7f8b07656fbd58ec6987
- Cited by
- 115
- References
- 44
- Citations by year
- 2026: 35 · 2025: 38 · 2024: 34 · 2023: 8
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diabetes Metabolic Syndrome and Obesity (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- King Saud University
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- GLP-1 receptor agonists, obesity, appetite suppression, gastric emptying, food preferences, taste sensitivity, weight loss, dietary intake
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


